News & Publications
Find our latest news and analysis here. From the daily Newsstand to the Quarterly Journal, we cover the full breadth of intellectual property law.
Written October 17, 2018
The US Court of Appeals for the First Circuit on October 15, 2018, reversed a district court order certifying a class of indirect purchasers of the drug Asacol to pursue antitrust claims against Allergan Inc., the drugmaker. Teamsters Union v. Warner Chilcott Ltd., 1st Cir., 10/15/18.
The plaintiffs alleged that Allergan predecessor Warner Chilcott, whose drug Asacol is used for the treatment of inflammatory bowel disease, illegally lengthened its monopoly by coordinating the withdrawal of Asacol from the market with the entry of Delzicol, a new drug with the same active ingredient and dosage. Doing so may have allowed Warner to preclude the possibility of market entry of generic drugs.
The district court certified the class while reasoning that no more than 10 percent of the class were brand-loyal, and therefore had not suffered any injury, however, the First Circuit disagreed, saying that 10 percent in the overall class was too many.
The plaintiffs alleged that Allergan predecessor Warner Chilcott, whose drug Asacol is used for the treatment of inflammatory bowel disease, illegally lengthened its monopoly by coordinating the withdrawal of Asacol from the market with the entry of Delzicol, a new drug with the same active ingredient and dosage. Doing so may have allowed Warner to preclude the possibility of market entry of generic drugs.
The district court certified the class while reasoning that no more than 10 percent of the class were brand-loyal, and therefore had not suffered any injury, however, the First Circuit disagreed, saying that 10 percent in the overall class was too many.
Broadcast Opportunities
Looking for opportunities to get published? Submit your work to the AIPLA Quarterly Journal or AIPLA Innovate Magazine.
Exhibitor and Sponsorship Opportunities
Highlight your brand at a premier intellectual property law event, webinar, podcast, or in one of our publications.
For rates, availability, or additional details, click here or contact:
Meghan Donohoe
COO
American Intellectual Property Law Association (AIPLA)
T| +1.703.415.1343
E| mdonohoe@aipla.org